Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FCL7V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,839
Award facts
- Contract value 100% obligated
- $1,839.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,839.12 for Repatha 140 mg/ml SureClick auto-injector pens on October 31, 2025, with completion scheduled for November 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Repatha is a PCSK9 inhibitor prescribed for cholesterol management and is included among the company's extensive pharmaceutical portfolio delivered through its DLA contract vehicle. The SPE2DX contract functions as a comprehensive global pharmaceutical support mechanism, enabling the company to supply brand-name and generic medications, vaccines, auto-injectors, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs and other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FCL7V?
SPE2DR26FCL7V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26FCL7V worth?
The government has obligated $1,839 on SPE2DR26FCL7V.
Is contract SPE2DR26FCL7V an order under another contract?
Yes. SPE2DR26FCL7V is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCL7V competed?
The extent of competition for SPE2DR26FCL7V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award